Dr. John H. Krystal, USAPresident, CINP

Prof. Barbara Sahakian, UKChair, CINP International

Scientific Programme Committee

Prof. Marina Picciotto, USACo-Chair, CINP International

Scientific Programme Committee

Prof. Siegfried Kasper, AustriaChair, Local Organizing Committee and CINP

President-Elect

Dates for your

Diary

July 2017Launch of conference programme/ Call for poster abstracts

and award applications

July 2017 Registration Open

12th Jan 2018 First deadline for early registration fee

12th Jan 2018 Deadline for poster abstract submission

12th Jan 2018 Deadline for Award applications

12th Jan 2018 Deadline for speaker abstracts for accepted symposia

12th May 2018 Second deadline for registration fee

16th June 2018 Opening Ceremony of CINP 2018

Saturday 16th June 2018

09.00-10.30

PCW1

Holly Lisanby

TMS

11.00-12.30 SAT1

PCW1

Eduard Vieta

Bipolar

14.30-16.00 SAT2

PCW3

Joseph Zohar

PTSD

16.45-18.00Welcome and

Awards Ceremony

PL - Plenary

S - Symposia

CP – Clinical Perspectives

PCW/ WS – Pre-Conference Workshop/ Education Workshop

CO – Corresponding Organisations

Key

Preliminary Programme

Sunday 17th June 2018

08.30-

08.45Opening Address

08.45-

09.30

PL01: The environment

and resilience against

mental illness

Andreas Meyer

Lindenberg, Germany

09.45-

11.30

Others Schizophrenia PTSD ADD Others CP01 WS01

S1: GABA regulation:

from mechanisms to

novel therapeutic

targets

S2 : The use of

technology in mental

illness and mental

wellbeing

S3: PTSD Genetics in

a military context

S4: ADHD across the

lifespan - biological

mechanisms underlying

disease onset and

persistence,

implications for

treatment

S5: CINP initiative for

public private

partnerships (PPPs)

for innovative CNS

drug development

Addiction Bipolar Disorders

The place of CINP

treatment guidelines for

bipolar disorder in

clinical practice:

controversies and

consensus

11.30-

13.00Poster Session and Lunch Women's Symposium CO1

13.00-

14.30SAT3 SAT4 SAT5 Details to follow Details to follow

14.45-

16.30

Depression Others Bipolar Disorders Addictive Disorders Depression CP02 WS02

S6: New approaches in

transcranial magnetic

stimulation for

depression

S7: New insights into

the role of

orbitofrontal cortex in

compulsive behavior

psychopathology and

its treatment

S8: Strategies to

prevent

neurobehavioral

progression and

suicide in bipolar

disorder

S9: Cannabis shapes

the morophologfical

and epigenetic

trajectory of

mesocorticolimbic brain

development relevant

to psychiatric

vulnerability

S10: Glutamate and

mood disorders: All is

not explained by

NMDA

Schizophrenia Childhood and

Adolescent Disorders

Advances in the

diagnosis of paediatric

mood disorders

16.45-

17.30

PL02: Suicidal subtypes:

improving phenotypes

to uncover underlying

biosignatures

Maria A Oqendo, USA

18.00-

19.30SAT6 SAT7 SAT8

Monday 18th June 2018

08.45-

09.30

PL03: Molecular

mechanisms of gene x

environment interactions

- implications for

diagnosis and treatment

of psychiatric disorders

Elisabeth Binder,

Germany

09.45-

11.30

Depression DepressionPresidential

symposiumAddictive Disorders OCD Schizophrenia WS03

S11 : Prediction of

disease vulnerability and

treatment response in

mood and anxiety

disorders

S12: Translational

research on

etiopathogenesis of

late-life cognitive

impairment and

depression: four

different approaches

toward the common

goal

Details to follow

S13: A translational

approach to reducing

drug-related

memories and

enhancing self-

control in drug

addiction

S14: Translational

neuroscience of

obsessive-

compulsive

disorders

S15: Schizophrenia:

From genes to

changed brain

function

Progress of the

neuroscience-based

nomenclature

(NbN) for

Psychotropic drugs

11.30-

13.00Poster Session and Lunch

Young Scientist

Committee MeetingCO2

13.00-

14.30SAT9 SAT10 SAT11

14.45-

16.30

Depression Depression Addictive Disorders Schizophrenia LATE BREAKING CP03 WS04

S16: The antidepressant

controversy: what do

reanalyses of controlled

trials reveal regarding the

true efficacy of

antidepressants?

S17: It's all in the wiring:

Brain circuits involved in

depression and

antidepressant actions

S18: Behavioural

addiction: a research

and clinical update

S19: Dopamine signal

intensity in

neuropsychiatric

disorders: etiology

and therapy

S20 Rapid acting

antidepressants

16.45-

17.30

PL04: Modeling and

predicting developmental

trajectories of

neuropsychiatric

dimensions

Noboru Hiroi, USA

18.00-

19.30SAT12 SAT13 SAT14

Tuesday 19th June 2018

08.45-

09.30

PL05: A circuits-first

approach to mental illness

Amit Etkin, USA

09.45-

11.30

Depression OCD Schizophrenia Depression Schizophrenia CP04 WS05

S21: Understanding the

mechanism of action of

ketamine-like drugs in

mood disorders and their

implementation in the

clinic

S22: Deep brain

stimulation for severe

OCD: effect and

mechanisms of STN

and nucleus

accumbens targets

S23: Recent updates

on controversial

issues in the

management of

schizophrenia

S24 : Neuroimaging

in the treatment of

depression - acute

neuronal response,

treatment effects

and recurrence

prediction

S25: NMDAR

dysfunction,

neuromodulatory

dysfunction and

glutathione deficit in

schizophrenia

pathogenesis

Treatment

Resistant

Depression

Neuropsycho-

pharmacology of the

endocannabinoid-

ome

11.30-

13.00Poster Session and Lunch General Assembly CO3

13.00-

13.45

PL06: Glutamatergic

GABAergic and

dopaminergic

abnormalities in

antipsychotic-naive first-

episode schizophrenia

patients: connected

disturbances or

independent biomarkers

for outcome?

Birte Glenthoej, Denmark

13.45-

15.30

Others Others Schizophrenia Depression LATE BREAKING CP05

S26: Microbiome and

neuropsychiatry - moving

towards mechanisms

S27: Psychedelic

medicine: the

therapeutic potential of

mind-altering

substances

S28: Developing new

medications for the

treatment of

schizophrenia:

failures and hopes

S29: Genes

epigenome and

environment in

pathophysiology of

brain illness

S30 Anxiety Disorders

and OCD

15.30-

16.15

PL07: Differential

influence of pre- and early

postnatal cannabis

exposure on the

developing brain

Tibor Harkany, Austria

16.15-

16.30Closing ceremony

Early Bird Registration

Now Open!Deadline 12th January 2018

www.cinp.org/vienna